National Health Investors, Inc. (NHI)

Trade Timeline

Risk Factors

• •Overall low fundamental quality and long-term score (both 20/100) increase the risk of a larger-than-typical post–ex-dividend drawdown not reflected fully in historical capture stats.
• •ATR of 2.21% indicates meaningful short-term price swings; adverse moves can overwhelm the $0.92 dividend (≈1.19% of price) during the short holding window.
• •Historical win rates (e.g., 64.9% for Buy 7d / Sell 1d and 58.8–63.9% across other windows) are favorable but far from guaranteed, with roughly one loss every three trades.
• •Medium confidence level and Tier 3 rating highlight model uncertainty and the possibility that future behavior diverges from historical averages.
• •Dividend capture returns rely on continued 100% 7–14 day gap fill behavior, which may not persist in stressed market or stock-specific news environments.

Action Checklist

• 1.Confirm current ex-dividend date (2025-12-31) and dividend amount ($0.92) have not changed.
• 2.Verify current price and yield near the intended entry date; re-check that yield is ~4.77% and the risk/reward still aligns with your plan.
• 3.If pursuing capture, schedule a limit-buy order approximately 7 days before ex-date, accounting for liquidity and spreads.
• 4.Predefine an exit plan to sell 1 trading day after ex-date, using either a limit order near historical capture expectations or a disciplined stop if volatility spikes.
• 5.Size the position so that a 2–3× ATR move (≈4–7%) against you remains within acceptable risk limits, given the 2.21% ATR.
• 6.Monitor for company-specific news (earnings, guidance, regulatory/tenant issues) that could invalidate the historical capture pattern or increase downside risk.
• 7.Avoid treating NHI as a core dividend holding unless quality metrics improve significantly; consider reallocating long-term capital to higher-quality, higher-score dividend names.